Matthew Cooperberg, MD, MPH on Biomarkers in Prostate Cancer Active Surveillance

Active Surveillance for #ProstateCancer in 2023 | Matthew Cooperberg, MDПодробнее

Forward Progress in Molecular Markers for Prostate CancerПодробнее

Active Surveillance in 2022 | Laurence Klotz, MD | PCRIПодробнее

Screening & Active Surveillance | Matthew Cooperberg, MD & Mark Moyad, MD | PCRIПодробнее

Updates in Prostate Cancer BiomarkersПодробнее

4.3.2020 Urology COViD Didactics - Prostate Cancer Screening, Diagnosis and Risk StratificationПодробнее

Biomarkers’ Integration with Clinical Parameters, Imaging, and Prognostic InstrumentsПодробнее

Localized Prostate Cancer: Progress Toward Personalized CareПодробнее

Active Surveillance with Dr. Laurence Klotz - ZERO Prostate Cancer Summit 2022Подробнее